The role of tumor necrosis factor alpha (TNF-α) in autoimmune disease and current TNF-α inhibitors in therapeutics

D Jang, AH Lee, HY Shin, HR Song, JH Park… - International journal of …, 2021 - mdpi.com
Tumor necrosis factor alpha (TNF-α) was initially recognized as a factor that causes the
necrosis of tumors, but it has been recently identified to have additional important functions …

Emerging roles of vascular cell adhesion molecule-1 (VCAM-1) in immunological disorders and cancer

DH Kong, YK Kim, MR Kim, JH Jang, S Lee - International journal of …, 2018 - mdpi.com
Tumor necrosis factor alpha (TNFα) is a pro-inflammatory cytokine that triggers the
expression of inflammatory molecules, including other cytokines and cell adhesion …

Drugs for autoimmune inflammatory diseases: from small molecule compounds to anti-TNF biologics

P Li, Y Zheng, X Chen - Frontiers in pharmacology, 2017 - frontiersin.org
Although initially described as an anti-tumor mediator, tumor necrosis factor-alpha (TNF) is
generally considered as the master pro-inflammatory cytokine. It plays a crucial role in the …

The yin and yang of co-inhibitory receptors: toward anti-tumor immunity without autoimmunity

A Schnell, L Bod, A Madi, VK Kuchroo - Cell research, 2020 - nature.com
Co-inhibitory receptors are important regulators of T-cell function that define the balance
between tolerance and autoimmunity. The immune regulatory function of co-inhibitory …

Exploration of the medical periodic table: towards new targets

NPE Barry, PJ Sadler - Chemical Communications, 2013 - pubs.rsc.org
Metallodrugs offer potential for unique mechanisms of drug action based on the choice of
the metal, its oxidation state, the types and number of coordinated ligands and the …

Pathogenesis, diagnosis and management of obstetric antiphospholipid syndrome: a comprehensive review

J Alijotas-Reig, E Esteve-Valverde… - Journal of clinical …, 2022 - mdpi.com
Antiphospholipid syndrome is an autoimmune disorder characterized by vascular
thrombosis and/or pregnancy morbidity associated with persistent antiphospholipid antibody …

Signaling pathways in the regulation of cytokine release syndrome in human diseases and intervention therapy

X Li, M Shao, X Zeng, P Qian, H Huang - Signal Transduction and …, 2021 - nature.com
Cytokine release syndrome (CRS) embodies a mixture of clinical manifestations, including
elevated circulating cytokine levels, acute systemic inflammatory symptoms and secondary …

Iridium (III) complexes as therapeutic and bioimaging reagents for cellular applications

KKW Lo, KY Zhang - RSC advances, 2012 - pubs.rsc.org
There is an emerging interest in applying inorganic and organometallic transition metal
complexes to biomolecular and cellular studies. The cytotoxic effects of these complexes on …

Tackling TNF-α in autoinflammatory disorders and autoimmune diseases: from conventional to cutting edge in biologics and RNA-based nanomedicines

V Andretto, S Dusi, S Zilio, M Repellin, D Kryza… - Advanced Drug Delivery …, 2023 - Elsevier
Autoinflammatory disorders and autoimmune diseases result from abnormal deviations of
innate and adaptive immunity that heterogeneously affect organs and clinical phenotypes …

A Metal‐Based Inhibitor of Tumor Necrosis Factor‐α

CH Leung, HJ Zhong, H Yang, Z Cheng… - Angewandte Chemie …, 2012 - Wiley Online Library
Tumor necrosis factor-a (TNF-a) is a pro-inflammatory cytokine that plays a critical role in key
biological processes, including haematopoiesis, immunity, and inflammation.[1] Aberrant …